NCT05016518View on ClinicalTrials.gov

Comparison of Quality of Recovery (QoR)-15 Scores Between Propofol and Remimazolam Anesthesia

NACompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

September 16, 2021

Primary Completion Date

May 18, 2022

Study Completion Date

May 20, 2022

Conditions
Patients Undergoing Thyroid Surgery for Neoplasm
Interventions
DRUG

Arm I (Propofol group)

Propfol group will be started and maintained total intravenous anesthesia with propofol and remifentanil .

DRUG

Arm II (Remimazolam group)

Remimazolam group will be started and maintained total intravenous anesthesia with remimazolam and remifentanil.

Trial Locations (1)

Unknown

Gangnam Severance Hospital, Seoul

All Listed Sponsors
lead

Gangnam Severance Hospital

OTHER

NCT05016518 - Comparison of Quality of Recovery (QoR)-15 Scores Between Propofol and Remimazolam Anesthesia | Biotech Hunter | Biotech Hunter